A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
Public ClinicalTrials.gov record NCT00240318. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 104-Week, Open-label, Multi-centre, Phase IIIb Study Evaluating the Effect of Treatment With Rosuvastatin 40 mg on Atherosclerotic Disease as Measured by Intravascular Ultrasound and Quantitative Coronary Angiography in Subjects Undergoing Coronary Angiography Who Have Coronary Artery Disease
Study identification
- NCT ID
- NCT00240318
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 450 participants
Conditions and interventions
Conditions
Interventions
- Rosuvastatin calcium Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2002
- Primary completion
- Oct 31, 2005
- Completion
- Oct 31, 2005
- Last update posted
- Nov 18, 2010
2002 – 2005
United States locations
- U.S. sites
- 24
- U.S. states
- 16
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | San Francisco | California | — | — |
| Research Site | Santa Rosa | California | — | — |
| Research Site | Stockton | California | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Site | Hartford | Connecticut | — | — |
| Research Site | Atlantis | Florida | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Maywood | Illinois | — | — |
| Research Site | Auburn | Maine | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | Petoskey | Michigan | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Saint Paul | Minnesota | — | — |
| Research Site | Buffalo | New York | — | — |
| Research Site | Valhalla | New York | — | — |
| Research Site | Williamsville | New York | — | — |
| Research Site | Chapel Hill | North Carolina | — | — |
| Research Site | Toledo | Ohio | — | — |
| Research Site | Danville | Pennsylvania | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00240318, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2010 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00240318 live on ClinicalTrials.gov.